Danaher announces $9.9 billion acquisition of Masimo

- By InnoNurse Staff -

Danaher Corporation announced on Feb. 17, 2026, that it has agreed to acquire Masimo Corporation, a manufacturer of pulse oximetry and patient monitoring technologies used primarily in acute care settings.

Under the terms of the agreement, Danaher will purchase all outstanding Masimo shares for $180 per share in cash, representing a total enterprise value of about $9.9 billion, including debt and net of acquired cash. The deal values Masimo at roughly 18 times its estimated 2027 EBITDA, or about 15 times EBITDA when expected synergies are included.

After the transaction closes, Masimo will operate as a standalone company within Danaher’s Diagnostics segment, alongside businesses such as Radiometer, Leica Biosystems, Cepheid, and Beckman Coulter Diagnostics. Danaher said Masimo’s sensor technologies and AI-enabled monitoring capabilities are expected to strengthen its diagnostics portfolio and expand its reach in patient monitoring.

Danaher expects the acquisition to be accretive to adjusted diluted earnings per share, contributing approximately $0.15–$0.20 in the first full year and about $0.70 by the fifth year after completion. The company also anticipates more than $125 million in annual cost synergies and over $50 million in annual revenue synergies by the fifth year. Masimo is projected to generate more than $530 million in EBITDA by 2027 and deliver high-single-digit core revenue growth over the long term.

The transaction is expected to close in the second half of 2026, subject to regulatory approvals and approval by Masimo shareholders. Danaher plans to finance the acquisition through cash on hand and debt financing.

Read more at Danaher

///

Other recent news and insights

Intellijoint Surgical Inc. and Vena Medical awarded $1.9 million from Ontario’s Life Sciences Scale-Up Fund

AI could help predict your risk of breast cancer in the next four years

New 3D material enables brain cells to communicate

TriZetto data breach: health tech giant reveals personal info of 3.4 million users may have been affected

Open 3D Human Organ Atlas lets users explore anatomy in unprecedented detail

Orchestrated multi-agent AI systems outperform single agents in health care

U.S. jury says Apple must pay Masimo $634 million over Apple Watch blood oxygen patent infringement

A federal jury in California ruled on Friday that Apple must pay Masimo, a medical-monitoring technology firm, $634 million in damages for violating a patent on blood-oxygen sensing tech used in the Apple Watch.
The verdict upheld Masimo’s claims that features like workout mode and heart rate notifications in the Apple Watch infringed the patent, according to a Masimo spokesperson. Apple has…

View On WordPress

Jury says Apple owes Masimo $634M for patent infringement

A federal jury in California dominated Friday that Apple should pay medical machine maker Masimo $634 million for infringing a patent on blood oxygen monitoring expertise.
Reuters reviews that the jury discovered that the Apple Watch’s exercise mode and coronary heart fee notification options violated Masimo’s patent.
“It is a vital win in our ongoing efforts to guard our improvements and mental…

Jury says Apple owes Masimo $634M for patent infringement

U.S. ITC scrutinizes redesigned Apple Watch blood oxygen feature

In August 2025, Apple reintroduced a redesigned version of the Blood Oxygen monitoring feature on the Apple Watch in the U.S., shifting data processing from the device to users’ iPhones to circumvent an ongoing patent dispute with health tech firm Masimo. This move came 18 months after Apple began selling certain Apple Watch models without the feature, following a U.S. International Trade…

View On WordPress

Vuelve el oxígeno en sangre al Apple Watch en Estados Unidos

El esperado sensor de Oxígeno en sangre Apple Watch finalmente regresa para los nuevos modelos vendidos en Estados Unidos. Esto marca un nuevo capítulo en la historia reciente del popular dispositivo. Apple ha confirmado que, mediante una actualización de software, los usuarios del Apple Watch Series 9 y Apple Watch Ultra 2 en dicho país podrán volver a disfrutar de esta capacidad de monitoreo de…

Vuelve el oxígeno en sangre al Apple Watch en Estados Unidos

Apple and Masimo Clash in U.S. Appeals Court Over Apple Watch Import Ban

Apple urged a U.S. appeals court to overturn a ruling that led to the removal of the blood-oxygen feature from its Apple Watches, following a patent dispute with medical tech company Masimo. The U.S. International Trade Commission (ITC) had previously ruled that Apple’s pulse oximetry technology infringed on Masimo’s patents, resulting in a temporary import ban on the Series 9 and Ultra 2 models.

Apple argued the decision unfairly impacted users and was based on a product Masimo hadn’t yet launched when it filed its complaint. Masimo countered that Apple misused its technology after failed collaboration talks and that a finished product wasn’t needed to enforce its patent rights. The court is now reviewing whether the ITC ruling was justified.

IP Consulting Group
📧 protect@ipconsultinggroups.com
🌐 www.ipconsultinggroups.com
📞 DC: +1 (202) 666-8377 | MD: +1 (240) 477-6361 | FL +1 (239) 292-6789

CareFusion GE Original Vital Signs Tsmperature Cable for GE Monitors, 400 Series, Dual, 0.5m/20in. REF: 2016998-001#edanse-12express #invasivebloodpressuresensor #generalelectric #bloodpressurecuff #geb1800

Apple wins $250 U.S. jury verdict in Masimo smartwatch patent case

Masimo W1 watch and smartphone app
Apple has secured a victory in its ongoing intellectual property dispute with Masimo. A federal jury in Delaware has ruled in favor of Apple, finding that earlier versions of Masimo’s W1 and Freedom smartwatches and their chargers infringed on two of Apple’s design patents. The jury determined that Masimo’s infringement was willful.
Blake Brittain for…

View On WordPress

Apple ve Masimo Arasındaki Patent Davası: Tazminat ve İhtimaller

Apple ve Masimo Arasındaki Patent Davası: Sonuçlar ve İhtimaller
Teknoloji dünyasının önde gelen isimleri Apple ve Masimo arasında gerçekleşen patent davası, sonuçlarıyla dikkat çekti. ABD’de Federal jüri, Masimo’nun belirli akıllı saat modellerinin Apple’ın tasarım patentlerini ihlal ettiğine hükmetti. Ancak bu davanın sonucu, Apple’ın beklediği tazminatın çok altında, sadece 250 dolarlık…

Apple ve Masimo Arasındaki Patent Davası: Tazminat ve İhtimaller

admin pic

Katy Perry s'associe à Denon, la marque d'écouteurs du groupe Masimo, pour promouvoir leurs nouveaux modèles True Wireless, les Denon PerL et PerL Pro. Cette annonce fait suite à une série de collaborations de célébrités avec des marques audio, soulignant la tendance actuelle de l'industrie à utiliser des figures publiques influentes pour attirer l'attention sur leurs produits.

Apple appeals ITC ban that halted Apple Watch sales in the U.S.

Apple Watch Series 6 and later models feature a Blood Oxygen sensor and app to conveniently measure the oxygen saturation of blood so users can better understand their overall fitness and wellness.
Apple is appealing a decision by the U.S. ITC that forced it to stop selling Apple Watch models after the agency claimed that Apple violated patents of a competitor.
Joseph Pisani for The Wall Street…

View On WordPress

Apple Watch Ban in Effect: Biden Administration Won’t Veto - Leaf&Core

Apple Watch import ban takes effect

The Blood Oxygen sensor on the back crystal of Apple Watch
The U.S. International Trade Commission’s (ITC) order has gone into effect as of December 26th, barring imports and sales of Apple Watches that use technology for reading blood-oxygen levels. Apple has included the pulse oximeter feature in Apple Watches starting with its Series 6 model in 2020.
Blake Brittain for Reuters:
‎

U.S.…

View On WordPress

Apple halts sales of Apple Watch Series 9 and Apple Watch Ultra 2 on its U.S. website

Apple Watch Series 6 and later models feature a Blood Oxygen sensor and app to conveniently measure the oxygen saturation of blood so users can better understand their overall fitness and wellness.
Apple has stopped selling the Apple Watch Series 9 and Apple Watch Ultra 2 smartwatches on its U.S. website. “Following December 24, 2023, Apple no longer sells Apple Watch units in the United States…

View On WordPress

New Apple Watches Banned Due To Patent Dispute

Production of the Apple Watch Series 9 and Apple Watch Ultra 2 will cease due to an ITC import ban caused by a patent dispute between Apple and Masimo over a pulse oximeter sensor. Masimo is a manufacturer of medical devices. The ban applies specifically to United States customers. The pulse oximeter in your Apple Watch tells you what your pulse and blood oxygen levels are. The Apple Watch SE…

View On WordPress

Denon annonserer nye ørepropper med “Adaptive Acoustic Technology”

View On WordPress

🖤🤍

Masimo demands ITC ban Apple Watch Series 6 sales in America

Masimo demands ITC ban Apple Watch Series 6 sales in America

Masimo is expanding its legal fight against Apple, filing a patent-infringement complaint at the U.S. International Trade Commission (ITC) that seeks to ban imports of the Apple Watch Series 6.
Apple Watch Series 6 with the distinct Braided Solo Loop and blue aluminum case.
Masimo claims that Apple Watchs Series 6 infringes five patents for devices that use light transmitted through the body to…

View On WordPress